← Back to Search

Dietary Supplement

SRW Cel System for Healthy Aging

Phase 2
Recruiting
Research Sponsored by TruDiagnostic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in epigenetic age from baseline to 12 months
Awards & highlights

Study Summary

This trial is testing whether the Cel System can help people age healthily by targeting the 9 Hallmarks of Aging.

Who is the study for?
This trial is for individuals aged 55 or older who are post-menopausal (if female), can follow the treatment plan, and have a smartphone to use an app. They must be able to read and speak English, consume supplements during the study, and not have any major health issues that could affect participation.Check my eligibility
What is being tested?
The SRW Cel System protocol targets all nine hallmarks of aging with three formulas combined with a lifestyle app. The goal is to see if this approach supports healthy aging by impacting these key biological factors.See study design
What are the potential side effects?
Potential side effects aren't specified but may include reactions typical of new supplements such as digestive discomfort, allergic reactions, or changes in energy levels. Close monitoring will help identify any unexpected effects.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in epigenetic age from baseline to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in epigenetic age from baseline to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Biological age
Secondary outcome measures
C-reactive protein
Inflammatory marker IL-6

Trial Design

1Treatment groups
Experimental Treatment
Group I: SRW Cel systemExperimental Treatment1 Intervention
Cel1, Cel2, Cel3 Patients will take all three supplements once daily. Patients will take 2 capsules of each supplement in the morning with food.

Find a Location

Who is running the clinical trial?

TruDiagnosticLead Sponsor
11 Previous Clinical Trials
436 Total Patients Enrolled
8 Trials studying Aging
326 Patients Enrolled for Aging
SRWUNKNOWN

Media Library

SRW Cel System (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05535608 — Phase 2
Aging Research Study Groups: SRW Cel system
Aging Clinical Trial 2023: SRW Cel System Highlights & Side Effects. Trial Name: NCT05535608 — Phase 2
SRW Cel System (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05535608 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the SRW Cel System been cleared by the Food & Drug Administration?

"Our team at Power has categorized the safety profile of SRW Cel System as a 2, since there is evidence that it does not cause harm but no clinical data to prove its efficacy."

Answered by AI

Is enrollment open for this experiment?

"Affirmative. The information hosted on clinicaltrials.gov states that the medical trial, which was first posted in August 2022, is still recruiting individuals to take part. 50 participants are needed at a single centre for this research endeavour."

Answered by AI

Who meets the criteria to take part in this experiment?

"This research trial is welcoming 50 enrollees aged between 55 and 90 who are experiencing the effects of aging. As well as this, all candidates must match these criteria: be of any gender or ethnicity; possess language proficiency in English; own a smartphone with app download capability; have access to a primary care physician; post-menopausal female participants only; abide by treatment plans and necessary lab tests, consume study supplements for duration of project."

Answered by AI

How many individuals are being enrolled in this research study?

"Affirmative. Clinicaltrials.gov documents this medical trial, whose inception was August 15th 2022, is recruiting patients as of September 9th 2022. With 50 participants needed from one location, the recruitment process is ongoing."

Answered by AI

Does this clinical trial accept participants younger than 35 years of age?

"The target population for this research is those aged 55-90."

Answered by AI

Who else is applying?

What state do they live in?
California
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
~19 spots leftby Mar 2025